Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.

dc.authoridArtac, Mehmet/0000-0003-2335-3354
dc.authoridPaksoy, Nail/0000-0003-4636-2595
dc.authorwosidArtac, Mehmet/AAF-8158-2020
dc.authorwosidSendur, Mehmet Ali Nahit/H-7555-2014
dc.authorwosidCoşkun, Hasan Şenol/C-2070-2016
dc.authorwosidPaksoy, Nail/HKF-3015-2023
dc.contributor.authorTural, Deniz
dc.contributor.authorOlmez, Omer Fatih
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorArtac, Mehmet
dc.contributor.authorOzhan, Nail
dc.contributor.authorAkar, Emre
dc.contributor.authorCakar, Burcu
dc.date.accessioned2024-06-12T11:22:28Z
dc.date.available2024-06-12T11:22:28Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.descriptionASCO Genitourinary Cancers Symposium (GU ASCO) -- FEB 11-13, 2021 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipASCOen_US
dc.identifier.doi10.1200/JCO.2021.39.6_suppl.409
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue6en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2021.39.6_suppl.409
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25945
dc.identifier.volume39en_US
dc.identifier.wosWOS:000636801500412en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleAssociation of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.en_US
dc.typeConference Objecten_US

Dosyalar